Phase I clinical trial of peptide vaccine for advanced gastric and colorectal cancer

Interventions: peptide vaccine therapy Primary outcome(s): We confirm the safety of the peptide vaccine against gastric and colorectal cancer patient. Study Design: Single arm Non-randomized